AICDA and neuroblastoma: Of special interest were two of the signatures identified: Signature 18, which is classically associated with neuroblastoma and appears during the progression of the disease, and signature 2, which appears during stabilization state and is associated to a wide variety of cancers, and was related to the activation of AID/APOBEC deaminase.